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Distinct multiple antigenic determinants of the attachment protein of Mycoplasma pneumoniae have been
identified by limited proteolytic cleavage, using specific monoclonal antibodies. Western blots prepared from
the gels containing the cleaved fragments were probed with antiserum against M. pneumoniae or monoclonal
antibodies. Five distinct bands with intact antigenic determinants were detected by the antiserum, of which two
bands were each reactable with two monoclonal antibodies. A sequential binding assay suggested that these
monoclonal antibodies recognized different antigenic sites of each band. These results demonstrate the existence
of multiple antigenic sites on the attachment protein and describe procedures that should prove useful for
identifying those antigenic sites critical to the specific attachment of M. pneumoniae.
Previous studies on the interaction of Mycoplasma pneu-
moniae with respiratory epithelium indicated that the spe-
cific attachment of viable mycoplasmas to the target host
cells was a prerequisite for the initiation of infection (9).
Subsequently, it was demonstrated that a surface protein,
designated P1, was involved in the attachment process (10).
Using a monoclonal antibody specific to P1, we showed
direct evidence that the protein was located on the surface of
the attachment tip of M. pneumoniae (7); the same antibody
also inhibited attachment. This finding has been subse-
quently confirmed by Feldner et al. (6) and Baseman et al.
(1), using monoclonal and monospecific antibodies, respec-
tively. Mild trypsin treatment of M. pneumoniae abolished
its attachment capacity, cleaved P1 protein, and resulted in
the appearance of P3 protein at a lower-molecular-weight
region (10). However, trypsin treatment did not destroy the
antigenic determinants of P1 protein recognized by the
monoclonal antibody (M218) used in our later study (7).
Monoclonal antibody M218 also reacted, in addition to P3,
with a faint band of very low molecular weight which was
thought to represent a portion cleaved from P1. This obser-
vation led to the suggestion that P1 molecules probably
possess several repeating amino acid sequences which form
multiple identical antigenic determinants (7). On the other
hand, biological activities other than attachment have been
attributed to P1 protein (5, 17). Feldner et al. (6) reported
that a monoclonal antibody specific to P1 protein inhibited
the gliding motility of M. pneumoniae, and studies of hem-
adsorption of M. pneumoniae by nonadhering mutants (5,
14) indicated that P1 was lost in some of the hemadsorption-
negative mutants. It is possible that these biological activi-
ties are mediated by different sites of P1 molecules. Eluci-
dation of the structural-functional relationships of P1 protein
by epitope mapping may lead to the identification of anti-
genic determinants relevant to the mechanism of attachment
and also contribute to a better understanding of other
biological activities attributed to P1. The present report
demonstrates the existence of multiple distinct determinants
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to P1 protein by the use of a collection of monoclonal
antibodies.
MATERIALS AND METHODS
Organisms. M. pneumoniae M129-B7 (ATCC 29342) was
used in this study. Cultures were maintained in Edward-
Hayflick medium supplemented with 20% agamma horse
serum, 10% yeast dialysate, and penicillin (1,000 U/ml) (4, 8).
Monolayer cultures were grown in glass prescription bottles.
After incubation at 37°C for 36 to 48 h, the medium was
decanted, and the organisms were rinsed three times with
phosphate-buffered saline (PBS), pH 7.2. The organisms were
then scraped into PBS, pelleted by centrifugation (12,000 x
g for 15 min), and processed for sodium dodecyl sulfate
(SIDS)-polyacrylamide gel electrophoresis or used for
immunization.
Antiserum and monoclonal antibodies. Antiserum against
M. pneumoniae organisms was produced in rabbits by
procedures described previously (16).
Hybridomas secreting monoclonal antibodies to P1 pro-
tein of M. pneumoniae were produced by hybridization of
spleen cells from BALB/c mice immunized with M. pneu-
moniae and SP2/0-Agl4 myeloma cells (ATCC CRL-1581)
by described procedures (7, 18). In another experiment,
spleen cells were obtained from mice immunized with the P1
band sliced off from a 7% SDS-gel. Hybridomas that pro-
duced antibodies against P1 protein were initially screened
by a solid-phase radioimmunoassay and then confirmed by
protein blot in combination with a radioimmunobinding
technique (12). Details of the solid-phase radioimmunoassay
have been described elsewhere (13). Monoclonal antibodies
in hybridoma culture fluids were concentrated by precipita-
tion with ammonium sulfate (45% saturation) and dialyzed
extensively against PBS, pH 7.4, in the cold. Concentrations
were adjusted to approximately 10 mg/ml, and sodium azide
was added (0.01%). The monoclonal antibodies were stored
at -200C.
Limited proteolysis of P1 protein in SDS-gels. Discontinu-
ous SDS-gel electrophoresis was performed by Laemmli's
method (15). Limited proteolytic cleavage of P1 protein
separated on SDS-gels was carried out by the procedure of
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FIG. 1. Saturation curves of monoclonal antibodies. Four mono-
clonal antibodies specific to P1 of M. pneumoniae were tested for
times required to saturate the solid-phase M. pneumoniae antigen by
a radioimmunoassay (12). M218 has the highest affinity for the
antigen, while all four monoclonal antibodies saturate the antigen by
4 h of incubation.
Cleveland et al. (2). P1 protein bands separated on a 7%
SDS-gel stained with Coomassie blue were cut off carefully
with a razor blade, trimmed to 5-mm width, and soaked in 10
ml of 0.125 M Tris hydrochloride buffer, pH 6.8, containing
0.1% SDS, 1 mM EDTA, and 10% glycerol for 30 min. The
gel slices were pushed to the bottom of the individual slots of
the second gel (4% stacking gel and 12% separation gel).
Spaces around the slices were filled by overlaying each slot
with 10 ,ul of the same buffer containing 20% glycerol.
Finally, 10 ,ul of this buffer containing 10% glycerol and 2.5
,ug of Staphylococcus aureus V-8 protease was overlaid into
each slot, and electrophoresis was performed in the normal
manner except that the current was turned off for 30 min
when the bromophenol blue dye reached the bottom of the
stacking gel. The stacking gel was 3.5 cm in height and the
separation gel was 7 cm in height.
Preparation of nitrocellulose blots and immunoradioauto-
graphy. Proteins separated on SDS-gels by electrophoresis
were transferred to nitrocellulose filters as described previ-
ously (12). To identify bands which retained the antigenic
determinants, nitrocellulose blots were incubated with rabbit
immune serum or monoclonal antibodies and imaged with
1251I-labeled goat anti-rabbit immunoglobulin G or goat anti-
mouse immunoglobulins (9). Radioautographs were pro-
duced with X-Omat-AR5 film (Eastman Kodak Co.) at
-80°C, using an intensifying screen (Du Pont Co.).
Sequential binding assay. The sequential binding assay was
modified from the solid-phase radioimmunoassay (13). To
determine whether or not two monoclonal antibodies bind to
the same epitope, the antibodies were added sequentially to
the antigen in microtiter wells followed by the 125I-labeled
goat anti-mouse immunoglobulins. Basically, a significant
rise in radioactivity counts will indicate that the two mono-
clonal antibodies bind to two distinct sites, whereas a
sequential incubation with two monoclonal antibodies spe-
cific to the same site will result in no increase in radioactivity
counts. A preliminary experiment was carried out to con-
struct the saturation curves for the four monoclonal antibod-
ies used in this study (Fig. 1). The results indicated that all
four monoclonal antibodies saturated the antigens after
about 4 h of incubation. Therefore, a 4-h incubation time was
chosen for the sequential binding assay. Following the
incubation of the first monoclonal antibody for 4 h, the
microtiter wells were washed three times with PBS contain-
ing 2% agamma horse serum, pH 7.2; then the second
monoclonal antibody was added to individual wells and
incubation was continued for another 4 h. After that, the
wells were rinsed two times with the PBS-agamma horse
serum and then incubated with 1251I-labeled rabbit anti-mouse
immunoglobulins (5 x 105 cpm in 50 ,u) for 1 h. Finally, the
wells were washed four times with PBS and swabbed with
cotton applicators, and the radioactivity was determined in a
gamma counter.
RESULTS AND DISCUSSION
When the P1 protein band of M. pneumoniae cut off from
a 7% SDS-gel was subjected to limited S. aureus V-8
protease cleavage and re-electrophoresed on a 12% SDS-gel,
in addition to a major band representing the S. aureus V-8
protease (Fig. 2, lane C), a number of faint bands were
visualized after staining with Coomassie blue (Fig. 2, lane
B); P1 remained as a single band if the V-8 protease was
omitted (Fig. 2, lane A). These observations indicate that P1
protein was cleaved by the S. aureus V-8 protease.
To determine whether antigenicity was preserved in these
protease-cleaved fragments, they were transferred to nitro-
A B C
FIG. 2. Cleavage of P1 protein with S. aureus V-8 protease.
Lane A, Untreated P1 migrated as a single band; lane B, Protease-
cleaved fragments of P1 migrated to the lower region of the gel; lane
C, S. aureus V-8 protease only, serving as a negative control. Gels
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FIG. 3. Immunoradioautographs of M. pneumoniae proteins
separated on a 10% SDS-gel and transferred to nitrocellulose filters.
Lane A, Incubated with rabbit immune serum and then imaged with
"'I1-labeled goat anti-rabbit immunoglobulin G. Lanes B to E, Same
preparation as in lane A, incubated with monoclonal antibodies
M218, P150, P155, and P244, respectively, and then imaged with
1251-labeled rabbit anti-mouse immunoglobulins. Results indicated
that all four monoclonal antibodies were specific to P1 protein.
cellulose filters and incubated with rabbit anti-M. pneumo-
niae immune serum or monoclonal antibodies. The speci-
ficity of the monoclonal antibodies is shown in Fig. 3. All
four monoclonal antibodies used in this study were directed
specifically against P1. Five bands were detectable with
rabbit immune serum (Fig. 4). Among the five bands, band 1
reacted with monoclonal antibodies M218 and P244 and band
4 reacted with monoclonal antibodies P150 and P155. There-
fore, bands 1 and 4 must possess antigenic determinants
different from each other. The failure of the four monoclonal
antibodies to react with bands 2, 3, and 5 indicates the
absence of the corresponding antigenic determinants on
bands 2, 3, and 5. However, the present data cannot rule out
the possible existence of unidentified antigenic determinants
which may be common to these different P1 fragments.
Likewise, no conclusion can be made as to whether bands 2,
3, and 5 share a common antigenic determinant(s) or not.
Although both M218 and P244 reacted with band 1 and
P150 and P155 reacted with band 4 it is still possible that
either or both band 1 and band 4 possess two distinct
antigenic determinants. To examine this possibility, a se-
quential binding assay was carried out. Sequential incuba-
tion of the solid-phase M. pneumoniae antigen with two
monoclonal antibodies (shown to bind to two different bands
in Fig. 4) resulted in significant increases in radioactivity
counts compared with double incubation with a single mono-
clonal antibody (Table 1). This additive effect obviously is
due to the binding of nonrelated monoclonal antibodies to
distinct antigenic determinants on P1 molecules. However,
when two monoclonal antibodies shown to react with the
same protease-cleaved fragments were used, different re-
sults were observed. For example, sequential incubation of
M218/P244 produced no additive effect over that of
M218/M218, implying that the two monoclonal antibodies
might react with the same antigenic determinant. In contrast,
when the sequence of incubation was reversed, P244 fol-
lowed by M218, a definite additive effect was observed,
suggesting the existence of two distinct antigenic determi-
nants on band 1. Similar results were obtained for the two
monoclonal antibodies, P150 and P155, which reacted with
band 4.
These results complicated our interpretation. Neverthe-
less, two explanations could account for the observations
which favor the existence of two distinct antigenic determi-
nants on both bands 1 and 4. The first possibility is that M218
and P244 probably bind to two different, but closely spaced,
sites with such structural configuration that the site for P244
is less accessible to the antibody molecules. Consequently,
the binding of M218 may interfere with the subsequent
binding of P244 by steric hindrance. Primary binding by P244
did not inhibit the binding of M218. An alternate explanation
is that the binding of M218 triggered a configurational change









FIG. 4. Immunoradioautographs of M. pneumoniae P1 protein
following protease treatment. P1 protein bands were cut off from a
7% SDS-gel, digested with S. aureus V-8 protease, re-electropho-
resed on a 12% SDS-gel, and transferred to nitrocellulose filters.
Lane A, Protease-digested P1 incubated with rabbit immune serum
and imaged with 251I-labeled goat anti-rabbit immunoglobulin G; five
bands with intact antigenic determinants were revealed. Lane B,
Untreated P1 migrated as a single band, indicating the purity of P1.
Lane C, Blank control with S. aureus V-8 protease only; the faint
bands represent nonspecific binding. Lanes D through G, Protease-
digested P1 incubated with monoclonal antibodies M218, P150,
P155, and P244, respectively, and imaged with 251I-labeled rabbit
anti-mouse immunoglobulins.
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a Details of the experimental procedure are described in Materials and
Methods. As shown in Fig. 4, both M218 and P244 recognized band 4, and
P150 and P155 recognized band 1.
and as a result blocked the site for P244. These explanations
may also apply to P155 and P150.
In summary, five distinct antigenic determinants of the P1
protein of M. pneumoniae have been identified by limited
proteolytic cleavage in combination with a sequential bind-
ing assay, using specific monoclonal antibodies. This ap-
proach appears to be suitable for antigenic analysis of
water-insoluble membrane-bound protein molecules which
are difficult to purify. However, the combined use of SDS-
gel-immunoblotting and limited protease cleavage for the
identification of antigenic determinants of P1 is not without
shortcomings. It is very probable that some of the antigenic
determinants on P1 molecules have been destroyed by either
the protease cleavage or the treatment with SDS and 2-
mercaptoethenol during the sample preparation. Thus, the
antigenic determinants identified by the monoclonal antibod-
ies and rabbit antiserum in the present study were essentially
those resistant to SDS and 2-mercaptoethanol. It is impor-
tant to be aware that the elucidation of the entire antigenic
structure of P1 will require the application of other tech-
niques. Nevertheless, we believe many more antigenic de-
terminants can be demonstrated on P1 molecules when
additional monoclonal antibodies are produced and other
proteases or chemical cleavage treatments are used.
Because of the important role that P1 protein plays in the
pathogenesis of M. pneumoniae infection (3, 5, 9) and the
recent demonstration that P1 is a major immunogen (11), the
significance of fine analysis of the antigenic composition of
P1 could be severalfold. First, it could provide information
useful in the investigation of the molecular basis of the
specific attachment of M. pneumoniae organisms to the
respiratory epithelium. Second, the precise identification of
an immunogenic determinant(s) relevant to this critical step
of M. pneumoniae infection and the determination of its
amino acid sequence could lead to the development of an
oligopeptide vaccine. In addition, the physical basis of other
biological activities, i.e., gliding motility and hemadsorption,
which have been attributed to P1 protein remains unclear. It
is likely that a large macromolecule such as P1 (molecular
weight, 190,000) could possess a number of biological activ-
ities mediated by different "sites" of the molecule. To define
the molecular basis for each of these biological activities by
elucidation of the structural-functional relationships of P1
protein is an extremely difficult and challenging task. How-
ever, the utilization of monoclonal antibodies corresponding
to distinct antigenic determinants to block these biological
activities in experimental systems may be helpful in deter-
mining whether these biological activities attributed to P1
protein are mediated by different sites of P1 molecules. Such
information should further define the role(s) of P1 in the
pathogenesis of M. pneumoniae disease.
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